← Back to catalogue

Atellica IM aHBe2

FDA UDI

Class II (US FDA UDI)

by Siemens Healthcare Diagnostics

Identity

Trade Name
Atellica IM aHBe2 FDA UDI
Generic Name
Hepatitis B virus e-antigen total antibody IVD, kit, chemiluminescent immunoassay FDA UDI
Device Name
Anti-HBe2 (aHBe2) – Atellica IM – RGT 50T FDA UDI
Model / Reference
10733021 FDA UDI
Description
Anti-HBe2 (aHBe2) – Atellica IM – RGT 50T FDA UDI

Identifiers

Catalog Number
10733021 FDA UDI
Primary DI / UDI-DI
00842768022678 FDA UDI
PMA Number
P200017 FDA UDI
FDA Product Code
LOM FDA UDI
GMDN Term
Hepatitis B virus e-antigen total antibody IVD, kit, chemiluminescent immunoassay FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
866.3172 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

No

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

No

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Hepatitis B virus e-antigen total antibody IVD, kit, chemiluminescent immunoassay

Atellica IM aHBe2 by Siemens Healthcare Diagnostics — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Hepatitis B virus e-antigen total antibody IVD, kit, chemiluminescent immunoassay.

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA UDI 223174b3-2a46-4fb9-9c47-f744d40dda49 37 fields · synced May 30, 2026